☰

Maria Hadjifrangiskou, Ph.D. - Publications

Affiliations: 
2007 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Microbiology Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Green HD, Van Horn GT, Williams T, Eberly A, Morales GH, Mann R, Hauter IM, Hadjifrangiskou M, Schmitz JE. Intra-strain colony biofilm heterogeneity in uropathogenic and the effect of the NlpI lipoprotein. Biofilm. 8: 100214. PMID 39184815 DOI: 10.1016/j.bioflm.2024.100214  0.348
2024 Brannon JR, Reasoner SA, Bermudez TA, Comer SL, Wiebe MA, Dunigan TL, Beebout CJ, Ross T, Bamidele A, Hadjifrangiskou M. Mapping niche-specific two-component system requirements in uropathogenic . Microbiology Spectrum. e0223623. PMID 38385738 DOI: 10.1128/spectrum.02236-23  0.363
2023 Hurst MN, Beebout CJ, Hollingsworth A, Guckes KR, Purcell A, Bermudez TA, Williams D, Reasoner SA, Trent MS, Hadjifrangiskou M. The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS. Msphere. e0005923. PMID 37676915 DOI: 10.1128/msphere.00059-23  0.341
2023 Brannon JR, Reasoner SA, Bermudez TA, Dunigan TL, Wiebe MA, Beebout CJ, Ross T, Bamidele A, Hadjifrangiskou M. Mapping Niche-specific Two-Component System Requirements in Uropathogenic . Biorxiv : the Preprint Server For Biology. PMID 37292752 DOI: 10.1101/2023.05.23.541942  0.358
2023 Morales G, Abelson B, Reasoner S, Miller J, Earl AM, Hadjifrangiskou M, Schmitz J. The Role of Mobile Genetic Elements in Virulence Factor Carriage from Symptomatic and Asymptomatic Cases of Escherichia coli Bacteriuria. Microbiology Spectrum. e0471022. PMID 37195213 DOI: 10.1128/spectrum.04710-22  0.331
2022 Sultana S, Crompton ME, Meurer K, Jankiewicz O, Morales GH, Johnson C, Horbach E, Hoffmann KP, Kr P, Shah R, Anderson GM, Mortimer NT, Schmitz JE, Hadjifrangiskou M, Foti A, et al. Redox-Mediated Inactivation of the Transcriptional Repressor RcrR is Responsible for Uropathogenic Escherichia coli's Increased Resistance to Reactive Chlorine Species. Mbio. e0192622. PMID 36073817 DOI: 10.1128/mbio.01926-22  0.401
2021 Beebout CJ, Sominsky LA, Eberly AR, Van Horn GT, Hadjifrangiskou M. Cytochrome bd promotes Escherichia coli biofilm antibiotic tolerance by regulating accumulation of noxious chemicals. Npj Biofilms and Microbiomes. 7: 35. PMID 33863914 DOI: 10.1038/s41522-021-00210-x  0.34
2020 Eberly AR, Beebout CJ, Tong CMC, Van Horn GT, Green HD, Fitzgerald MJ, De S, Apple EK, Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, McLean JA, Clayton DB, Stratton CW, Schmitz JE, ... Hadjifrangiskou M, et al. Data highlighting phenotypic diversity of urine-associated isolates. Data in Brief. 31: 105811. PMID 32566710 DOI: 10.1016/J.Dib.2020.105811  0.314
2020 Brannon JR, Dunigan TL, Beebout CJ, Ross T, Wiebe MA, Reynolds WS, Hadjifrangiskou M. Invasion of vaginal epithelial cells by uropathogenic Escherichia coli. Nature Communications. 11: 2803. PMID 32499566 DOI: 10.1038/S41467-020-16627-5  0.396
2019 Eberly AR, Beebout CJ, Carmen Tong CM, Van Horn GT, Green HD, Fitzgerald MJ, De S, Apple EK, Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, McLean JA, Clayton DB, Stratton CW, Schmitz JE, ... Hadjifrangiskou M, et al. Defining a Molecular Signature for Uropathogenic versus Urocolonizing Escherichia coli: The Status of the Field and New Clinical Opportunities. Journal of Molecular Biology. PMID 31794727 DOI: 10.1016/J.Jmb.2019.11.008  0.423
2019 Beebout CJ, Eberly AR, Werby SH, Reasoner SA, Brannon JR, De S, Fitzgerald MJ, Huggins MM, Clayton DB, Cegelski L, Hadjifrangiskou M. Respiratory Heterogeneity Shapes Biofilm Formation and Host Colonization in Uropathogenic Escherichia coli. Mbio. 10. PMID 30940709 DOI: 10.1128/Mbio.02400-18  0.426
2018 Magana M, Sereti C, Ioannidis A, Mitchell CA, Ball AR, Magiorkinis E, Chatzipanagiotou S, Hamblin MR, Hadjifrangiskou M, Tegos GP. Options and Limitations in Clinical Investigation of Bacterial Biofilms. Clinical Microbiology Reviews. 31. PMID 29618576 DOI: 10.1128/Cmr.00084-16  0.381
2018 Dale JL, Raynor MJ, Ty MC, Hadjifrangiskou M, Koehler TM. A Dual Role for theMaster Virulence Regulator AtxA: Control of Sporulation and Anthrax Toxin Production. Frontiers in Microbiology. 9: 482. PMID 29599764 DOI: 10.3389/Fmicb.2018.00482  0.626
2018 Steiner BD, Eberly AR, Hurst MN, Zhang EW, Green HD, Behr S, Jung K, Hadjifrangiskou M. Evidence of Cross-Regulation in Two Closely Related Pyruvate-Sensing Systems in Uropathogenic Escherichia coli. The Journal of Membrane Biology. PMID 29374286 DOI: 10.1007/S00232-018-0014-2  0.54
2018 Eberly A, Beebout C, Brannon J, De S, Fitzgerald M, Baroni C, Clayton D, Hadjifrangiskou M. MP23-17 CYTOCHROME BD -I IS A POTENTIAL TARGET FOR ERADICATING UROPATHOGENIC E. COLI BIOFILMS Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.749  0.34
2017 Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW, Schmitz JE, Hadjifrangiskou M. Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment. International Journal of Molecular Sciences. 18. PMID 28973965 DOI: 10.3390/Ijms18102077  0.411
2017 Breland EJ, Eberly AR, Hadjifrangiskou M. An Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli Infections. Frontiers in Cellular and Infection Microbiology. 7: 162. PMID 28536675 DOI: 10.3389/Fcimb.2017.00162  0.422
2017 Behr S, Kristoficova I, Witting M, Breland EJ, Eberly AR, Sachs C, Schmitt-Kopplin P, Hadjifrangiskou M, Jung K. Identification of a High-Affinity Pyruvate Receptor in Escherichia coli. Scientific Reports. 7: 1388. PMID 28469239 DOI: 10.1038/S41598-017-01410-2  0.4
2017 Breland EJ, Zhang EW, Bermudez T, Martinez CR, Hadjifrangiskou M. The histidine residue of QseC is required for canonical signaling between QseB and PmrB in uropathogenic Escherichia coli. Journal of Bacteriology. PMID 28396353 DOI: 10.1128/Jb.00060-17  0.416
2017 Abana CM, Brannon JR, Ebbott RA, Dunigan TL, Guckes KR, Fuseini H, Powers J, Rogers BR, Hadjifrangiskou M. Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli. Microbiologyopen. PMID 28332311 DOI: 10.1002/mbo3.466  0.308
2017 Guckes KR, Breland EJ, Zhang EW, Hanks SC, Gill NK, Algood HM, Schmitz JE, Stratton CW, Hadjifrangiskou M. Signaling by two-component system noncognate partners promotes intrinsic tolerance to polymyxin B in uropathogenic Escherichia coli. Science Signaling. 10. PMID 28074004 DOI: 10.1126/Scisignal.Aag1775  0.396
2016 Shaffer CL, Zhang EW, Dudley AG, Dixon BR, Guckes KR, Breland EJ, Floyd KA, Casella DP, Algood HM, Clayton DB, Hadjifrangiskou M. Purine biosynthesis metabolically constrains intracellular survival of uropathogenic E. coli. Infection and Immunity. PMID 27795353 DOI: 10.1128/Iai.00471-16  0.438
2016 Brannon JR, Hadjifrangiskou M. The arsenal of pathogens and antivirulence therapeutic strategies for disarming them. Drug Design, Development and Therapy. 10: 1795-806. PMID 27313446 DOI: 10.2147/Dddt.S98939  0.364
2016 Floyd KA, Mitchell CA, Eberly AR, Colling SJ, Zhang EW, DePas W, Chapman MR, Conover M, Rogers BR, Hultgren SJ, Hadjifrangiskou M. "The UbiI (VisC) aerobic ubiquinone synthase is required for expression of type 1 pili, biofilm formation, and pathogenesis in uropathogenic Escherichia coli". Journal of Bacteriology. PMID 27161114 DOI: 10.1128/Jb.00030-16  0.479
2016 Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, Romero-Gallo J, Krishna US, Delgado A, Gomez MA, Good JA, Almqvist F, Skaar EP, Correa P, Wilson KT, ... Hadjifrangiskou M, et al. Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system. Oncogene. PMID 27157617 DOI: 10.1038/Onc.2016.158  0.323
2016 Shaffer CL, Good JA, Kumar S, Krishnan KS, Gaddy JA, Loh JT, Chappell J, Almqvist F, Cover TL, Hadjifrangiskou M. Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens. Mbio. 7. PMID 27118587 DOI: 10.1128/Mbio.00221-16  0.404
2016 Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis. Mbio. 7. PMID 27073089 DOI: 10.1128/Mbio.00104-16  0.478
2015 Floyd KA, Meyer AE, Nelson G, Hadjifrangiskou M. The yin-yang driving urinary tract infection and how proteomics can enhance research, diagnostics, and treatment. Proteomics. Clinical Applications. PMID 26255866 DOI: 10.1002/Prca.201500018  0.397
2015 Floyd KA, Moore JL, Eberly AR, Good JA, Shaffer CL, Zaver H, Almqvist F, Skaar EP, Caprioli RM, Hadjifrangiskou M. Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili. Plos Pathogens. 11: e1004697. PMID 25738819 DOI: 10.1371/Journal.Ppat.1004697  0.48
2015 Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proceedings of the National Academy of Sciences of the United States of America. 112: E871-80. PMID 25675528 DOI: 10.1073/Pnas.1500374112  0.46
2014 Greene SE, Pinkner JS, Chorell E, Dodson KW, Shaffer CL, Conover MS, Livny J, Hadjifrangiskou M, Almqvist F, Hultgren SJ. Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli. Mbio. 5: e02038. PMID 25352623 DOI: 10.1128/Mbio.02038-14  0.418
2013 Guckes KR, Kostakioti M, Breland EJ, Gu AP, Shaffer CL, Martinez CR, Hultgren SJ, Hadjifrangiskou M. Strong cross-system interactions drive the activation of the QseB response regulator in the absence of its cognate sensor. Proceedings of the National Academy of Sciences of the United States of America. 110: 16592-7. PMID 24062463 DOI: 10.1073/Pnas.1315320110  0.468
2013 Hung C, Zhou Y, Pinkner JS, Dodson KW, Crowley JR, Heuser J, Chapman MR, Hadjifrangiskou M, Henderson JP, Hultgren SJ. Escherichia coli biofilms have an organized and complex extracellular matrix structure. Mbio. 4: e00645-13. PMID 24023384 DOI: 10.1128/Mbio.00645-13  0.41
2013 Kostakioti M, Hadjifrangiskou M, Hultgren SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harbor Perspectives in Medicine. 3: a010306. PMID 23545571 DOI: 10.1101/Cshperspect.A010306  0.392
2012 Kostakioti M, Hultgren SJ, Hadjifrangiskou M. Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics. Virulence. 3: 592-4. PMID 23154288 DOI: 10.4161/Viru.22364  0.381
2012 Hadjifrangiskou M, Gu AP, Pinkner JS, Kostakioti M, Zhang EW, Greene SE, Hultgren SJ. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. Journal of Bacteriology. 194: 6195-205. PMID 22984258 DOI: 10.1128/Jb.01012-12  0.489
2012 Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection Infection and Immunity. 80: 2826-2834. PMID 22665375 DOI: 10.1128/Iai.00283-12  0.444
2012 Hadjifrangiskou M, Hultgren SJ. What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli. Virulence. 3: 231-3. PMID 22546905 DOI: 10.4161/Viru.19763  0.431
2011 Hadjifrangiskou M, Kostakioti M, Hultgren SJ. Antitoxins: therapy for stressed bacteria. Nature Chemical Biology. 7: 345-7. PMID 21587255 DOI: 10.1038/Nchembio.584  0.351
2011 Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Molecular Microbiology. 80: 1516-29. PMID 21542868 DOI: 10.1111/J.1365-2958.2011.07660.X  0.499
2009 Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Molecular Microbiology. 73: 1020-31. PMID 19703104 DOI: 10.1111/J.1365-2958.2009.06826.X  0.578
2008 Hadjifrangiskou M, Koehler TM. Intrinsic curvature associated with the coordinately regulated anthrax toxin gene promoters. Microbiology (Reading, England). 154: 2501-12. PMID 18667583 DOI: 10.1099/Mic.0.2007/016162-0  0.654
2007 Hadjifrangiskou M, Chen Y, Koehler TM. The alternative sigma factor sigmaH is required for toxin gene expression by Bacillus anthracis. Journal of Bacteriology. 189: 1874-83. PMID 17189374 DOI: 10.1128/Jb.01333-06  0.663
Show low-probability matches.